We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
-3.52%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.19B
AUM Growth
-$316M
Cap. Flow
-$35.9M
Cap. Flow %
-0.86%
Top 10 Hldgs %
8.69%
Holding
711
New
42
Increased
245
Reduced
345
Closed
69

Top Buys

Rank Stock Value
1
VMI icon
Valmont Industries
VMI
+$21.7M
2
BOOT icon
Boot Barn
BOOT
+$16.8M
3
UPBD icon
Upbound Group
UPBD
+$15.6M
4
WCC
WESCO International
WCC
+$13.2M
5
OZK icon
Bank OZK
OZK
+$12.9M

Top Sells

Rank Stock Value
1
B
Barnes Group Inc.
B
+$25.9M
2
VBTX
Veritex Holdings
VBTX
+$13.9M
3
VRNA
Verona Pharma
VRNA
+$12.5M
4
COOP
Mr. Cooper
COOP
+$12M
5
HURN icon
Huron Consulting
HURN
+$10.9M

Sector Composition

Rank Sector Weight
1 Financials 20.65%
2 Healthcare 18.1%
3 Industrials 18.1%
4 Technology 12.71%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROX icon
626
Tronox
TROX
$1.02B
$130K ﹤0.01%
18,523
-135,989
-88% -$1.17M
AXTI icon
627
AXT Inc
AXTI
$4.79B
$120K ﹤0.01%
85,245
-830,215
-91% -$1.59M
ARCT icon
628
Arcturus Therapeutics
ARCT
$209M
$118K ﹤0.01%
11,130
+143
+1% +$2.27K
SLND icon
629
Southland Holdings
SLND
$38.4M
$108K ﹤0.01%
36,036
-6
-0% -$19
INTT icon
630
inTEST
INTT
$166M
$101K ﹤0.01%
14,393
-80,676
-85% -$669K
IMNM icon
631
Immunome
IMNM
$2.98B
$99.1K ﹤0.01%
14,725
+204
+1% +$1.96K
BDTX icon
632
Black Diamond Therapeutics
BDTX
$120M
$98.5K ﹤0.01%
63,523
-370,270
-85% -$776K
CMPS
633
Compass Pathways
CMPS
$1.81B
$98.4K ﹤0.01%
34,415
+439
+1% +$1.69K
RCKT icon
634
Rocket Pharmaceuticals
RCKT
$376M
$98.2K ﹤0.01%
14,725
-23,483
-61% -$232K
NTLA icon
635
Intellia Therapeutics
NTLA
$1.69B
$92.5K ﹤0.01%
13,013
+166
+1% +$1.68K
CGEM icon
636
Cullinan Oncology
CGEM
$1.26B
$88.1K ﹤0.01%
11,643
-99,406
-90% -$954K
DSGN icon
637
Design Therapeutics
DSGN
$911M
$55.5K ﹤0.01%
14,383
+117
+0.8% +$558
ABSI icon
638
Absci
ABSI
$1.57B
– –
-102,995
Closed -$270K
AMBA icon
639
Ambarella
AMBA
$3.62B
– –
-21,681
Closed -$1.58M
ARCB icon
640
ArcBest
ARCB
$3.04B
– –
-19,444
Closed -$1.81M
ARKO icon
641
ARKO Corp
ARKO
$506M
– –
-189,148
Closed -$1.25M
ASPN icon
642
Aspen Aerogels
ASPN
$509M
– –
-224,475
Closed -$2.67M
ASYS icon
643
Amtech Systems
ASYS
$267M
– –
-42,325
Closed -$231K
AXON
644
Axon Enterprise
AXON
$51.7B
– –
-356
Closed -$212K
BPOP icon
645
Popular Inc
BPOP
$11.2B
– –
-8,554
Closed -$805K
BRKR icon
646
Bruker
BRKR
$8.7B
– –
-49,388
Closed -$2.9M
BV icon
647
BrightView Holdings
BV
$1.05B
– –
-148,125
Closed -$2.37M
CBT icon
648
Cabot Corp
CBT
$4.54B
– –
-8,573
Closed -$783K
CMCO icon
649
Columbus McKinnon
CMCO
$561M
– –
-138,150
Closed -$5.14M
CRDO icon
650
Credo Technology Group
CRDO
$45.3B
– –
-22,504
Closed -$1.51M
24 25
26
27 28

Similar funds

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Kennedy Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Kennedy Capital Management held 711 positions worth $4.19B, down 7% from $4.5B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Kennedy Capital Management's Q1 2025 filing shows 42 new, 245 increased, 345 reduced and 69 closed positions. Its largest new stake was Adaptive Biotechnologies: 1,268,574 shares worth $9.43M. The largest sale was Barnes Group Inc., an estimated $25.9M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Kennedy Capital Management's largest Q1 2025 buy was Adaptive Biotechnologies: 1,268,574 shares worth $9.43M.
  • Kennedy Capital Management added most to Valmont Industries in Q1 2025, an estimated $21.7M increase.
  • Kennedy Capital Management's biggest Q1 2025 reduction was Veritex Holdings, cutting an estimated $13.9M.
  • Kennedy Capital Management fully exited Barnes Group Inc. in Q1 2025, selling an estimated $25.9M.
  • Kennedy Capital Management's ten largest holdings make up 8.7% of its $4.19B portfolio in Q1 2025.
  • Kennedy Capital Management opened 42 new positions and closed 69 in Q1 2025.
  • Kennedy Capital Management's portfolio value fell 7% quarter-over-quarter to $4.19B.

Based on Kennedy Capital Management's 13F filing for Q1 2025, filed 13 May 2025.